Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Rx Patent Reform Gets Renewed Interest From GOP As Alternative To Price Negotiation
Oct 18 2019
•
By
Derrick Gingery
The House Ways and Means Committee is one of several committees to consider the Pelosi drug pricing bill. • Source: File photo
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
More from Legislation
More from Pink Sheet